Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 4,369	$ 2,875
Accounts receivable, net, including related parties	1,125	709
Inventory	1,372	990
Prepaid expenses and other current assets	1,743	783
Total current assets	8,609	5,357
Property and equipment, net	1,432	1,770
Goodwill	1,362	1,325
Intangible assets, net	1,062	1,313
Other assets	401	497
Total assets	12,866	10,262
Current liabilities:
Accounts payable and accrued expenses	2,687	2,383
Deferred revenue	178	0
Development loan	10,000	5,000
Revolving credit facility, including accrued interest	10,153	10,458
Unfunded commitment to joint venture	1,684	1,688
Accrued payroll and benefits	1,325	1,159
Total current liabilities	26,027	20,688
Development loans, net of current portion	0	10,000
Promissory note	16,327	16,169
Total liabilities	42,354	46,857
Commitments and contingencies (Note 8)
Total convertible preferred stock	0	85,658
Stockholders’ deficit:
Common stock, $0.0001 par value; 750,000,000 shares authorized and 35,266,496 shares issued and outstanding as of September 30, 2020; 29,012,034 shares authorized and 4,220,998 shares issued and outstanding as of December 31, 2019	4	0
Additional paid-in capital	128,385	22,404
Accumulated deficit	(157,112)	(143,915)
Accumulated other comprehensive loss	(765)	(742)
Total stockholders’ deficit	(29,488)	(122,253)
Total liabilities, convertible preferred stock and stockholders’ deficit	12,866	10,262
Series 1 Preferred Stock
Current liabilities:
Total convertible preferred stock	0	39,658
Series 2 Preferred Stock
Current liabilities:
Total convertible preferred stock	0	30,000
Series 3 Preferred Stock
Current liabilities:
Total convertible preferred stock	$ 0	$ 16,000